Radioactive seed localization (RSL) of nonpalpable breast lesions for surgical excision
Record ID 32013000146
English
Authors' recommendations:
An estimated 13% of women in the United States will develop breast cancer during their lifetimes with close to 40,000 deaths per year. Increased utilization of screening mammography and better imaging methods have resulted in more breast cancers being detected as radiographic lesions only, i.e., before they are large enough for palpation(nonpalpable lesions). This has led to an increased need for image-guided localization of nonpalpable breast lesions prior to surgical excision or biopsy. The current standard of care for lesion localization is wire localization (WL), which involves the insertion of a wire into the breast lesion under radiologic guidance on the day of surgery. Radioactive seed localization (RSL) has been developed as an alternative to WL.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
The report may be purchased from:http://www.hayesinc.com/hayes/crd/?crd=14230
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Iodine Radioisotopes
- Radiopharmaceuticals
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2012 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.